questionsmedicales.fr
Système endocrine
Glandes endocrines
Gonades
Gonades : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Dysfonction gonadique
Tests hormonaux
Échographie
Analyse sanguine
Anomalies gonadiques
Fertilité
Cancer des gonades
Marqueurs tumoraux
Échographie
Anomalies gonadiques
Symptômes
5
Insuffisance gonadique
Troubles de la libido
Déséquilibre hormonal
Changements d'humeur
Inflammation gonadique
Douleurs abdominales
Cancer des gonades
Masse palpable
Hyperplasie gonadique
Virilisation
Prévention
5
Prévention
Mode de vie sain
Vaccination
Cancer gonadique
Infections gonadiques
Rapports protégés
Examens réguliers
Bilan hormonal
Cancer des gonades
Dépistage
Traitements
5
Insuffisance gonadique
Thérapie hormonale
Cancer des gonades
Chirurgie
Dysfonction érectile
Thérapie hormonale
Hyperplasie gonadique
Médicaments hormonaux
Infections gonadiques
Antibiotiques
Complications
5
Insuffisance gonadique
Fertilité
Cancer des gonades
Métastases
Hyperplasie gonadique
Troubles menstruels
Traitements hormonaux
Effets secondaires
Infections gonadiques
Douleurs chroniques
Facteurs de risque
5
Cancer des gonades
Facteurs de risque
Mode de vie
Santé gonadique
Médicaments
Fonction gonadique
Infections sexuellement transmissibles
Fertilité
Facteurs environnementaux
Santé gonadique
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Gonades : Questions médicales les plus fréquentes",
"headline": "Gonades : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Gonades : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-31",
"dateModified": "2025-04-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Gonades"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Glandes endocrines",
"url": "https://questionsmedicales.fr/mesh/D004702",
"about": {
"@type": "MedicalCondition",
"name": "Glandes endocrines",
"code": {
"@type": "MedicalCode",
"code": "D004702",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A06.300"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Ovaire",
"alternateName": "Ovary",
"url": "https://questionsmedicales.fr/mesh/D010053",
"about": {
"@type": "MedicalCondition",
"name": "Ovaire",
"code": {
"@type": "MedicalCode",
"code": "D010053",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A06.300.312.497"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Corps jaune",
"alternateName": "Corpus Luteum",
"url": "https://questionsmedicales.fr/mesh/D003338",
"about": {
"@type": "MedicalCondition",
"name": "Corps jaune",
"code": {
"@type": "MedicalCode",
"code": "D003338",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A06.300.312.497.278"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Follicule ovarique",
"alternateName": "Ovarian Follicle",
"url": "https://questionsmedicales.fr/mesh/D006080",
"about": {
"@type": "MedicalCondition",
"name": "Follicule ovarique",
"code": {
"@type": "MedicalCode",
"code": "D006080",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A06.300.312.497.535"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Testicule",
"alternateName": "Testis",
"url": "https://questionsmedicales.fr/mesh/D013737",
"about": {
"@type": "MedicalCondition",
"name": "Testicule",
"code": {
"@type": "MedicalCode",
"code": "D013737",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A06.300.312.782"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Gonades",
"alternateName": "Gonads",
"code": {
"@type": "MedicalCode",
"code": "D006066",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Izabela Rams-Pociecha",
"url": "https://questionsmedicales.fr/author/Izabela%20Rams-Pociecha",
"affiliation": {
"@type": "Organization",
"name": "Department of Comparative Anatomy, Institute of Zoology and Biomedical Research, Jagiellonian University, 30-387 Krakow, Poland."
}
},
{
"@type": "Person",
"name": "Paulina C Mizia",
"url": "https://questionsmedicales.fr/author/Paulina%20C%20Mizia",
"affiliation": {
"@type": "Organization",
"name": "Department of Comparative Anatomy, Institute of Zoology and Biomedical Research, Jagiellonian University, 30-387 Krakow, Poland."
}
},
{
"@type": "Person",
"name": "Rafal P Piprek",
"url": "https://questionsmedicales.fr/author/Rafal%20P%20Piprek",
"affiliation": {
"@type": "Organization",
"name": "Department of Comparative Anatomy, Institute of Zoology and Biomedical Research, Jagiellonian University, 30-387 Krakow, Poland."
}
},
{
"@type": "Person",
"name": "Serge Nef",
"url": "https://questionsmedicales.fr/author/Serge%20Nef",
"affiliation": {
"@type": "Organization",
"name": "Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland. Electronic address: serge.nef@unige.ch."
}
},
{
"@type": "Person",
"name": "Isabelle Stévant",
"url": "https://questionsmedicales.fr/author/Isabelle%20St%C3%A9vant",
"affiliation": {
"@type": "Organization",
"name": "Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Injection Site Reactions Before and After Intramuscular Injection Technique Revision: A Postmarketing Analysis of NALDEBAIN® From 2017 to 2022.",
"datePublished": "2023-05-04",
"url": "https://questionsmedicales.fr/article/37160663",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.6859/aja.202303_61(1).0002"
}
},
{
"@type": "ScholarlyArticle",
"name": "Injection Site Reactions with Long-Term Pegcetacoplan Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Brief Report.",
"datePublished": "2023-09-14",
"url": "https://questionsmedicales.fr/article/37707673",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12325-023-02653-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Injection Site Reaction to Various Insulins as Type III Allergy With Urticarial Vasculitis in a Patient With Type I Diabetes Mellitus.",
"datePublished": "2022-12-07",
"url": "https://questionsmedicales.fr/article/36669070",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/DAD.0000000000002356"
}
},
{
"@type": "ScholarlyArticle",
"name": "Fremanezumab-associated injection site alopecia.",
"datePublished": "2024-08-12",
"url": "https://questionsmedicales.fr/article/39134332",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bcr-2024-260741"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lower injection-site reactions and long-term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113: Results from a post-hoc analysis of a double-blind, randomized, phase III comparative study and its open-label extension in patients with rheumatoid arthritis.",
"datePublished": "2022-10-17",
"url": "https://questionsmedicales.fr/article/36253032",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1756-185X.14462"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Système endocrine",
"item": "https://questionsmedicales.fr/mesh/D004703"
},
{
"@type": "ListItem",
"position": 3,
"name": "Glandes endocrines",
"item": "https://questionsmedicales.fr/mesh/D004702"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gonades",
"item": "https://questionsmedicales.fr/mesh/D006066"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Gonades - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Gonades",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Gonades",
"description": "Comment diagnostiquer une dysfonction gonadique ?\nQuels examens pour évaluer la santé des gonades ?\nQuels signes indiquent une anomalie des gonades ?\nComment détecter un cancer des gonades ?\nQuel rôle joue l'échographie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D006066?mesh_terms=Injection+Site+Reaction#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Gonades",
"description": "Quels symptômes d'une insuffisance gonadique ?\nComment reconnaître un déséquilibre hormonal ?\nQuels signes d'inflammation des gonades ?\nQuels symptômes d'un cancer des gonades ?\nQuels symptômes d'une hyperplasie gonadique ?",
"url": "https://questionsmedicales.fr/mesh/D006066?mesh_terms=Injection+Site+Reaction#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Gonades",
"description": "Comment prévenir les maladies gonadiques ?\nQuel rôle des vaccinations dans la prévention ?\nComment éviter les infections gonadiques ?\nQuels examens réguliers pour la santé gonadique ?\nComment réduire le risque de cancer des gonades ?",
"url": "https://questionsmedicales.fr/mesh/D006066?mesh_terms=Injection+Site+Reaction#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Gonades",
"description": "Quels traitements pour l'insuffisance gonadique ?\nComment traiter un cancer des gonades ?\nQuelles options pour la dysfonction érectile ?\nComment gérer une hyperplasie gonadique ?\nQuels traitements pour les infections gonadiques ?",
"url": "https://questionsmedicales.fr/mesh/D006066?mesh_terms=Injection+Site+Reaction#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Gonades",
"description": "Quelles complications d'une insuffisance gonadique ?\nQuels risques liés à un cancer des gonades ?\nQuelles complications d'une hyperplasie gonadique ?\nQuels effets secondaires des traitements hormonaux ?\nQuelles complications des infections gonadiques ?",
"url": "https://questionsmedicales.fr/mesh/D006066?mesh_terms=Injection+Site+Reaction#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Gonades",
"description": "Quels facteurs de risque pour le cancer des gonades ?\nComment le mode de vie influence-t-il la santé gonadique ?\nQuels médicaments peuvent affecter les gonades ?\nQuel impact des infections sur la santé gonadique ?\nQuels facteurs environnementaux influencent les gonades ?",
"url": "https://questionsmedicales.fr/mesh/D006066?mesh_terms=Injection+Site+Reaction#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction gonadique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic se fait par des tests hormonaux et des examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels examens pour évaluer la santé des gonades ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses sanguines et des échographies peuvent être réalisées."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une anomalie des gonades ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des irrégularités menstruelles ou des problèmes de fertilité peuvent indiquer une anomalie."
}
},
{
"@type": "Question",
"name": "Comment détecter un cancer des gonades ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens d'imagerie et des marqueurs tumoraux sont utilisés pour le dépistage."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'échographie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie permet de visualiser les structures gonadiques et détecter des anomalies."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une insuffisance gonadique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, troubles de la libido et irrégularités menstruelles sont fréquents."
}
},
{
"@type": "Question",
"name": "Comment reconnaître un déséquilibre hormonal ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements d'humeur, de poids et de libido peuvent signaler un déséquilibre."
}
},
{
"@type": "Question",
"name": "Quels signes d'inflammation des gonades ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs abdominales, fièvre et gonflement peuvent indiquer une inflammation."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'un cancer des gonades ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des masses palpables, douleurs et changements dans les habitudes urinaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une hyperplasie gonadique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des menstruations irrégulières et des signes de virilisation peuvent être présents."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies gonadiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, une alimentation équilibrée et des examens réguliers aident."
}
},
{
"@type": "Question",
"name": "Quel rôle des vaccinations dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations, comme contre le HPV, peuvent prévenir des cancers gonadiques."
}
},
{
"@type": "Question",
"name": "Comment éviter les infections gonadiques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pratiquer des rapports protégés et éviter les partenaires multiples réduit le risque."
}
},
{
"@type": "Question",
"name": "Quels examens réguliers pour la santé gonadique ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des bilans hormonaux et des échographies peuvent être recommandés selon l'âge."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de cancer des gonades ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabac, maintenir un poids santé et se faire dépister régulièrement."
}
},
{
"@type": "Question",
"name": "Quels traitements pour l'insuffisance gonadique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies hormonales substitutives sont souvent prescrites."
}
},
{
"@type": "Question",
"name": "Comment traiter un cancer des gonades ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Chirurgie, chimiothérapie et radiothérapie sont des options de traitement."
}
},
{
"@type": "Question",
"name": "Quelles options pour la dysfonction érectile ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments, des dispositifs ou des thérapies hormonales peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Comment gérer une hyperplasie gonadique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments hormonaux et parfois une intervention chirurgicale sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels traitements pour les infections gonadiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antibiotiques ou antiviraux sont prescrits selon l'infection."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une insuffisance gonadique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des problèmes de fertilité et des troubles osseux."
}
},
{
"@type": "Question",
"name": "Quels risques liés à un cancer des gonades ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des métastases et des complications liées aux traitements peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une hyperplasie gonadique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut causer des troubles menstruels et un risque accru de cancer."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires des traitements hormonaux ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements d'humeur, des nausées et des risques thromboemboliques peuvent se produire."
}
},
{
"@type": "Question",
"name": "Quelles complications des infections gonadiques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des douleurs chroniques et des problèmes de fertilité."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le cancer des gonades ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Antécédents familiaux, âge avancé et exposition à des substances cancérigènes augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il la santé gonadique ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'obésité et le stress peuvent affecter la fonction gonadique."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent affecter les gonades ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains stéroïdes et médicaments anticancéreux peuvent altérer la fonction gonadique."
}
},
{
"@type": "Question",
"name": "Quel impact des infections sur la santé gonadique ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections sexuellement transmissibles peuvent endommager les gonades et affecter la fertilité."
}
},
{
"@type": "Question",
"name": "Quels facteurs environnementaux influencent les gonades ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition à des produits chimiques et à des radiations peut nuire à la santé gonadique."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 27/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Comparative Anatomy, Institute of Zoology and Biomedical Research, Jagiellonian University, 30-387 Krakow, Poland.
Doctoral School of Exact and Natural Sciences, Jagiellonian University, 30-348 Krakow, Poland.
Publications dans "Gonades" :
2 publications dans cette catégorie
Affiliations :
Department of Comparative Anatomy, Institute of Zoology and Biomedical Research, Jagiellonian University, 30-387 Krakow, Poland.
Doctoral School of Exact and Natural Sciences, Jagiellonian University, 30-348 Krakow, Poland.
Publications dans "Gonades" :
2 publications dans cette catégorie
Affiliations :
Department of Comparative Anatomy, Institute of Zoology and Biomedical Research, Jagiellonian University, 30-387 Krakow, Poland.
Publications dans "Gonades" :
2 publications dans cette catégorie
Affiliations :
Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland. Electronic address: serge.nef@unige.ch.
Publications dans "Gonades" :
2 publications dans cette catégorie
Affiliations :
Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.
Publications dans "Gonades" :
2 publications dans cette catégorie
Affiliations :
STU-UMT Joint Shellfish Research Laboratory, Shantou University, Shantou, 515063, China. ikhwanuddin@umt.edu.my.
Institute of Tropical Aquaculture, Universiti Malaysia Terengganu, 21030, Kuala Terengganu, Malaysia. ikhwanuddin@umt.edu.my.
Publications dans "Gonades" :
2 publications dans cette catégorie
Affiliations :
School of Marine Sciences, Sun Yat-Sen University, Zhuhai, 519082, China.
Publications dans "Gonades" :
2 publications dans cette catégorie
Affiliations :
School of Marine Sciences, Sun Yat-Sen University, Zhuhai, 519082, China.
Publications dans "Gonades" :
2 publications dans cette catégorie
Affiliations :
School of Marine Sciences, Sun Yat-Sen University, Zhuhai, 519082, China. lujianguo@mail.sysu.edu.cn.
Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Zhuhai, 519080, China. lujianguo@mail.sysu.edu.cn.
Guangdong Provincial Key Laboratory of Marine Resources and Coastal Engineering, Guangzhou, 510275, Guangdong, China. lujianguo@mail.sysu.edu.cn.
Pearl River Estuary Marine Ecosystem Research Station, Ministry of Education, Zhuhai, 519000, China. lujianguo@mail.sysu.edu.cn.
Publications dans "Gonades" :
2 publications dans cette catégorie
Publications dans "Gonades" :
2 publications dans cette catégorie
Publications dans "Gonades" :
2 publications dans cette catégorie
Publications dans "Gonades" :
2 publications dans cette catégorie
Publications dans "Gonades" :
1 publication dans cette catégorie
Affiliations :
Servicio de Endocrinología, Hospital de Pediatría 'Prof. Dr. Juan Pedro Garrahan', Buenos Aires, Argentina.
Publications dans "Gonades" :
1 publication dans cette catégorie
Affiliations :
Servicio de Endocrinología, Hospital de Pediatría 'Prof. Dr. Juan Pedro Garrahan', Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Publications dans "Gonades" :
1 publication dans cette catégorie
Affiliations :
Servicio de Endocrinología, Hospital de Pediatría 'Prof. Dr. Juan Pedro Garrahan', Buenos Aires, Argentina.
Publications dans "Gonades" :
1 publication dans cette catégorie
Affiliations :
Servicio de Endocrinología, Hospital de Pediatría 'Prof. Dr. Juan Pedro Garrahan', Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Publications dans "Gonades" :
1 publication dans cette catégorie
Affiliations :
Servicio de Endocrinología, Hospital de Pediatría 'Prof. Dr. Juan Pedro Garrahan', Buenos Aires, Argentina.
Publications dans "Gonades" :
1 publication dans cette catégorie
Affiliations :
Servicio de Endocrinología, Hospital de Pediatría 'Prof. Dr. Juan Pedro Garrahan', Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Publications dans "Gonades" :
1 publication dans cette catégorie
Affiliations :
Servicio de Endocrinología, Hospital de Pediatría 'Prof. Dr. Juan Pedro Garrahan', Buenos Aires, Argentina.
Publications dans "Gonades" :
The NALDEBAIN® has been available since 2017, and high incidence of injection reactions in the phase 3 study has been reported. Since the first year in the market, the injection site reactions were st...
Individual case safety reports (ICSRs) and ADRs were classified by system organ class and preferred term. The reporting rate of ICSRs was used to evaluate the impact of the new IM instruction and pack...
A total of 37 ICSRs were identified from pharmacovigilance reports. Among them, 51% of IM injection-related reactions were reported after one single dose of NALDEBAIN administration. The reporting rat...
Injection site reactions were common after intramuscularly administered oil-based agents during the first year which is later markedly reduced by changing the length of the needle and injection educat...
Pegcetacoplan is a targeted complement component 3 (C3) therapy approved for adults with paroxysmal nocturnal hemoglobinuria (PNH; US) or PNH plus anemia despite C5-targeted therapy for ≥ 3 months (EU...
Patients from PEGASUS enrolled in the 307 OLE continued pegcetacoplan subcutaneous self-administration twice or three times weekly or every 3 days for an additional 48 weeks. ISRs were coded as advers...
As of August 27, 2021, 58/64 patients from PEGASUS completed an additional 48 weeks of treatment in the 307 OLE (median treatment duration 337.0 [range 55-344] days); 95.3% (61/64) of patients achieve...
Though ISRs were common, most were mild, and the percentage of patients reporting ISRs declined from PEGASUS through the 307 OLE. Patient compliance remained high, and no patients discontinued because...
ClinicalTrials.gov identifiers: NCT03500549 (PEGASUS) and NCT03531255 (307 OLE)....
Injection site reactions are defined as skin reactions at the injection site to drugs administered subcutaneously. Pathophysiologically, these reactions are based on different immunological mechanisms...
Calcitonin gene-related peptide (CGRP) inhibitors, in the form of injectable monoclonal antibodies, are a newer class of drugs for the prevention of migraine headaches. In clinical trials, they have b...
YLB113 biosimilar was evaluated in an open-label extension single-arm study to assess long-term safety, efficacy, and immunogenicity in patients with rheumatoid arthritis (RA). We also report post-hoc...
Participants from the phase III, double-blind, randomized, 96 week equivalence study who completed the final visit received 50 mg YLB113 subcutaneously every 2 weeks. Key safety end points were assess...
Of 201 participants, 184 (91.5%) completed the study. Treatment-emergent AEs were experienced by 93.5% and severe AEs by 10.0% of participants. The discontinuation rate due to AEs was 2.0%. Overall, 2...
YLB113 demonstrated long-term safety and sustained efficacy for up to 96 weeks. Patients on YLB113 experienced significantly lower ISRs and ISE in a post-hoc analysis of the phase III study when compa...
A male in his 70s developed a rash on his lower abdomen after changing his subcutaneous injection drug from dulaglutide to tirzepatide. The rash diminished after stopping tirzepatide injection. This c...
Dupilumab is a humanized monoclonal antibody approved for the treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP), asthma, atopic dermatitis, eosinophilic esophagitis, and prurigo nodula...
Cabotegravir (CAB) + rilpivirine (RPV) dosed monthly or every 2 months is a complete long-acting (LA) regimen for the maintenance of human immunodeficiency virus type 1 virologic suppression. Across t...
We present pooled ISR characteristics and outcomes for participants receiving CAB + RPV LA through week 96 of the FLAIR and ATLAS-2M studies, and survey results from healthcare providers (HCPs) giving...
Overall, 8453 ISRs were reported by 801 participants receiving ≥1 injection of CAB LA/RPV LA. Most ISRs were mild to moderate in severity (grade 1-2, 99%), with a median duration of 3 days (interquart...
Taken together, the data demonstrate favorable tolerability with CAB + RPV LA injections over the long term and simple techniques routinely used by injectors to help optimize the administration of CAB...
Transient swelling is common after lip injections with hyaluronic acid (HA) based fillers. Swelling and other injection-site reactions may relate to the injection procedure itself, or to gel propertie...
To evaluate safety and effectiveness of lip injections with two HA fillers manufactured using different gel technologies....
In a study sample of 40 subjects, treatment with two soft tissue filler product (HA...
In subjects treated with HA...
The intensity of early-onset swelling, and other injection-site reactions was lower in subjects treated with HA...
Biologic selection for psoriasis treatment should take into account numerous factors including injection site reactions (ISRs) such as swelling at the injection site, pain, burning, erythema, all poss...
A 6-months observational real life study was performed involving psoriasis patients. Inclusion criteria were age ≥ 18 years, moderate-to-severe psoriasis diagnosis since at least 1 year, patients bein...
234 patients were included: 32.5% received an anti-TNF-alpha drug, 9.4% received anti-IL12/23, 32.5% received an anti-IL17, 25.6% received an anti-IL23. 51.2% of study population reported at least one...
Our study highlighted that each different class of biologics for psoriasis was linked to ISRs. These events are more frequently reported with anti-TNF-alpha and anti-IL17....